AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023

Go back to AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023

JPMorgan Resumes Amgen (AMGN) at Neutral

October 20, 2023 7:09 AM EDT

JPMorgan analyst Chris Schott resumes coverage on Amgen (NASDAQ: AMGN) with a Neutral rating and a price target of $270.00.

The analyst comments "We are moving to a Neutral rating on AMGN from Not Rated, with a December 2024 PT of $270 (Neutral rating and December 2023 PT... More